Morphine Continuous Infusion Preparation: 1 mg/hour IV
To prepare a morphine continuous infusion delivering 1 mg/hour, use a standardized concentration of 1 mg/mL by mixing 50 mg of morphine sulfate in 50 mL of 0.9% sodium chloride (normal saline), then run the infusion at 1 mL/hour using a programmable infusion pump 1.
Preparation Method
Standard Concentration Options
The FDA-approved morphine sulfate injection label provides specific mixing examples for continuous infusions 1:
- For 1 mg/mL concentration: Mix 20 mL of morphine sulfate 25 mg/mL injection with 480 mL of 5% dextrose in water (D5W) or normal saline
- For 0.5 mg/mL concentration: Mix 10 mL of morphine sulfate 25 mg/mL injection with 490 mL of D5W or normal saline
Practical Preparation for 1 mg/hour Delivery
Most practical approach:
- Take morphine sulfate injection 50 mg/mL: 1 mL (50 mg)
- Add to 49 mL of 0.9% sodium chloride
- Final volume: 50 mL
- Final concentration: 1 mg/mL
- Infusion rate: 1 mL/hour = 1 mg/hour
Alternatively, using morphine sulfate 25 mg/mL:
- Take 2 mL (50 mg total)
- Add to 48 mL of 0.9% sodium chloride
- Same final concentration and rate
Critical Safety Points
Equipment Requirements
- Must use a programmable infusion pump to maintain constant infusion rate 1
- Smart pumps with standardized concentration libraries reduce preparation errors by 41.2% 2
Stability Considerations
- Morphine 1 mg/mL in normal saline is stable for 14 days at room temperature (23°C) 3
- Do NOT refrigerate or freeze: Concentrations ≥50 mg/mL precipitate when stored at 4°C, and even after rewarming, substantial microparticulate contamination (>20,000 particles/mL) persists 4
- Store at controlled room temperature (20-25°C) in the dark 5
Common Preparation Errors to Avoid
Research shows 61.5% of manually-prepared morphine infusions deviate from target concentration, with some errors exceeding 100% 6. Key pitfalls:
- Volume overage in ampoules: Morphine ampoules contain excess volume beyond the labeled amount; failure to account for this causes concentration errors 6
- Inappropriate syringe size selection: Using syringes that are too large or small for the volumes being measured increases inaccuracy 6
- Final volume errors: 33.3% of preparations exceed the target 50 mL volume 6
Administration Precautions
- Administer SLOWLY: Rapid IV administration causes chest wall rigidity 1
- NOT for intrathecal or epidural use 1
- Inspect solution visually for particulate matter and discoloration before administration 1
Dosing Context
For continuous infusions in severe chronic pain (particularly cancer pain), the FDA label specifies 1:
- Loading dose: 15 mg or higher IV push prior to starting infusion
- Infusion range: 0.8 to 80 mg/hour (though doses up to 144 mg/hour have been used)
- Starting dose of 1 mg/hour is appropriate for opioid-naïve patients or those requiring low-dose continuous analgesia
The NCCN guidelines note that for opioid-naïve patients requiring parenteral morphine, initial doses of 2-5 mg IV are recommended 7, making a 1 mg/hour continuous infusion a conservative, appropriate starting point.
Renal Function Warning
Use caution in patients with fluctuating renal function: Morphine-6-glucuronide (active metabolite) accumulates renally and may cause neurologic toxicity 7.